Care and Management of Osteoarthritis in Adults (NICE Guideline)

Summary of NICE advice on OA assessment and treatment.

Pegloticase for Treating Severe Debilitating Chronic Tophaceous Gout (TA291)

Abatacept for Treating Rheumatoid Arthritis After the Failure of Conventional Disease-Modifying Anti-Rheumatic Drugs (TA280)

Tocilizumab for the Treatment of Rheumatoid Arthritis (TA247)

Golimumab for the Treatment of Ankylosing Spondylitis (TA233)

Golimumab for the Treatment of Rheumatoid Arthritis After the Failure of Previous Disease-Modifying Anti-Rheumatic Drugs (TA225)

Golimumab for the Treatment of Psoriatic Arthritis (TA220)

Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis after the Failure of a TNF Inhibitor (TA195)

Etanercept, Infliximab and Adalimumab for the Treatment of Psoriatic Arthritis (TA199)

Febuxostat for the Management of Hyperuricaemia in People with Gout (TA164)

Load More